Davidson Investment Advisors’s AstraZeneca AZN Stock Holding History

Davidson Investment Advisors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20.6M	Sell	108,676 -6,665	-6%	-$1.25M	0.84%	44
2026 Q1	$22.7M	Sell	115,341 -4,707	-4%	-$908K	0.98%	35
2025 Q4	$22.1M	Buy	120,048 +750	+0.6%	+$132K	0.92%	36
2025 Q3	$18.3M	Buy	119,298 +1,103	+0.9%	+$167K	0.78%	51
2025 Q2	$16.5M	Buy	118,195 +1,079	+0.9%	+$151K	0.74%	60
2025 Q1	$17.2M	Buy	117,116 +3,228	+3%	+$467K	0.85%	50
2024 Q4	$14.9M	Buy	113,888 +1,048	+0.9%	+$147K	0.73%	57
2024 Q3	$17.6M	Buy	112,840 +4,996	+5%	+$806K	0.85%	51
2024 Q2	$16.8M	Buy	107,844 +1,341	+1%	+$202K	0.87%	45
2024 Q1	$14.4M	Buy	106,503 +4,222	+4%	+$559K	0.75%	63
2023 Q4	$13.8M	Buy	+102,281	New	+$13.3M	0.79%	60

Other funds holding AZN

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

CDDEC

Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return

MIF

Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

ZIC

ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return

Davidson Investment Advisors's AZN Position: Q2 2026 in Review

Davidson Investment Advisors reduced its AstraZeneca (AZN) stake by 5.8% in Q2 2026, selling an estimated $1.25M and leaving 108,676 shares worth $20.6M. The position accounts for 0.84% of the portfolio, ranked #44.

Davidson Investment Advisors first reported a position in AZN in Q4 2023 and has held it in 11 quarters since. The position peaked at $22.7M in Q1 2026. 443 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Davidson Investment Advisors held 108,676 shares of AstraZeneca worth $20.6M as of Q2 2026.
Davidson Investment Advisors sold 6,665 AstraZeneca shares in Q2 2026, an estimated $1.25M.
AstraZeneca made up 0.84% of Davidson Investment Advisors's portfolio in Q2 2026, its #44 holding.
Davidson Investment Advisors first reported a position in AstraZeneca in Q4 2023 and has held it in 11 quarters since.
Davidson Investment Advisors's AstraZeneca position peaked at $22.7M in Q1 2026.
443 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Davidson Investment Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.